Apple's boss resumes role as CEO after bout with disease
After six months off the job, Apple cofounder Steve Jobs is back in his commanding role and CEO of the company, according to its spokespeople. Mr. Jobs’ battle with the side effects of his pancreatic cancer treatment left him in need of a liver transplant and forced him to take a medical leave of absence in January. Mr. Jobs, according to reports confirmed by a Tennessee hospital, received a liver transplant two months ago and is recovering.
Today Apple spokesman Steve Dowling stated, "Steve Jobs is back to work. He is at Apple a few days a week and working from home the other days. We're glad to have him back."
Bloggers and analysts have scrutinized the effect Mr. Jobs’ presence -- or his absence -- has on Apple in excruciating detail. There are varied opinions of exactly how critical he is to the company. Some have gone as far as to say Mr. Jobs is so important that Apple is breaking laws in failing to disclose to its shareholders more details on his health.
Meanwhile debate over whether favoritism was involved in his receiving an organ transplant also is ongoing. The Tennessee hospital which confirmed the transplant denied such allegations.
Currently, people receiving liver transplants have a 58 percent chance of surviving 15 years. Mr. Jobs is currently 54. He founded Apple when he was only 22 in 1976.
"The Space Elevator will be built about 50 years after everyone stops laughing" -- Sir Arthur C. Clarke
|
DailyTech Poll
Which web browser do you use on your primary personal machine?
44 Comments
Most Popular ArticlesEasy Fix to Prevent Microsoft From Bricking Xbox 360s HDDs Arrives November 18, 2009, 6:41 AM Built Around the Browser, Google's Chrome OS Launches, Reinvents the Operating System November 19, 2009, 2:40 PM Update: Potential Fix for 1 Million Banned Xbox 360's Has Arrived November 13, 2009, 12:00 PM OCZ Technology Announces 3.5" 1TB Colossus SSDs November 17, 2009, 6:48 PM GM Sheds Light on Volt's Greatest Problems, How it Hopes to Overcome Them November 18, 2009, 12:19 PM
|